Steroid‐related AEs ‐ not reported · adults with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
St. George's Respiratory Scale score (change from baseline) · adults with asthma
1 finding from 1 review
Severe exacerbations requiring hospitalisation over the study period · adults with asthma
ICS dose reduction showed no clear difference in exacerbation requiring hospitalisation compared with no change (low certainty).
1 finding from 1 review
FEV1 · adults with asthma
1 finding from 1 review
Asthma control · adults with asthma
1 finding from 1 review
Steroid‐related AEs · adults with asthma
It is very uncertain whether ICS dose reduction changes steroid‐related AEs compared with no change (very low certainty).
1 finding from 1 review
Change in AQLQ · adults with asthma
1 finding from 1 review
FEV1 (L) · adults with asthma
1 finding from 1 review
Exacerbation: hospital 17 weeks · adults with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Asthma control (short asthma morbidity score) · adults with asthma
1 finding from 1 review
Lung function: FEV1 mL (change from baseline) · adults and children with cystic fibrosis
1 finding from 1 review
Other measures of lung function: mean change from baseline in FEV1 AUC0-4h (% predicted) after tiotropium 5.0 µg · adults and children with cystic fibrosis
1 finding from 1 review
Change in baseline trough FEV1 · adults and children with cystic fibrosis
1 finding from 1 review
Participant‐reported outcomes: quality of life (measured by CFQ‐R) · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events after tiotropium 5.0 µg · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other measures of lung function · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Lung function: FEV1 mL (change from baseline) · adults and children with cystic fibrosis
1 finding from 1 review
Participant‐reported outcomes: quality of life (measured by CFQ‐R) · adults and children with cystic fibrosis
1 finding from 1 review
Adverse events after tiotropium 5.0 µg · adults and children with cystic fibrosis
LAMAs showed no clear difference in adverse events after tiotropium 5.0 µg compared with placebo (high certainty).
1 finding from 1 review